Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022

Rhea-AI Summary

Bioventus (Nasdaq: BVS) announced it will report its financial results for Q4 and fiscal year 2021 on March 10, 2022, before the market opens. A conference call hosted by management will follow at 8:30 a.m. Eastern Time to discuss the results and provide a business update. The call can be accessed via phone or through a live webcast on the Investor Relations section of Bioventus' website. The webcast will be available for replay until March 9, 2023.

DURHAM, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter and fiscal year 2021 before the market opens on Thursday, March 10, 2022. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.

To participate in the conference call, dial 1-844-945-2085 (domestic) or +1-442-268-1266 (international) and provide the access code 7388064.

A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until March 9, 2023.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for pain treatment, restorative therapies and bone graft substitutes. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com

Media Contact:
Jamica Whitaker
919-973-8312
jamica.whitaker@bioventus.com

FAQ

When will Bioventus report its financial results for Q4 2021?

Bioventus will report its financial results for Q4 2021 on March 10, 2022.

What time is the Bioventus conference call to discuss financial results?

The conference call to discuss financial results will be held at 8:30 a.m. Eastern Time on March 10, 2022.

How can I access the Bioventus conference call?

You can access the Bioventus conference call by dialing 1-844-945-2085 for domestic calls or +1-442-268-1266 for international calls, using the access code 7388064.

Will the Bioventus conference call be available for replay?

Yes, the webcast of the conference call will be archived and available for replay until March 9, 2023.